EFDID: 236500EFD: View Filing

Issuer: Akers Biosciences, Inc. (0001321834) - D

Accession: 0001493152-17-003835 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001321834
  • Entity Name:
    Akers Biosciences, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    NEW JERSEY
  • Year of Inc:
    Over 5 years ago
  • Address:
    201 GROVE RD
    THOROFARE, NJ 08086
  • Persons:
    Related Persons 7
    John Gormally
    Executive Officer 
    Chief Executive Officer
    Gary Rauch
    Executive Officer 
    VP, Finance and Treasurer
    Thomas Knox
    Director 
    Non-Executive Chairman
    Raymond Akers
    Executive Officer, Director 
    Secretary
    Brandon Knox
    Director
    Robert E. Andrews
    Director
    Raza Bokhari
    Director
EDGAR: Offering Information
  • Accession Date:
    04/13/2017
  • First Sale Date:
    03/30/2017
  • Offering Amount:
    $2,027,760
  • Amount Sold:
    $2,027,760
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
None None Joseph Gunnar & Co., LLC 24795 All States
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Akers Biosciences, Inc./s/ John J. GormallyJohn J. GormallyChief Executive Officer2017-04-13